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Introduction
Diabetes mellitus is not one disease with a defined
genetic origin, but many diseases with related symptoms.
Most cases of this disease can be classified as Type I,
insulin dependent (usually juvenile onset) , or Type II,
insulin non-dependent (usually adult onset) 1 The term,
diabetes mellitus, was first coined in the seventeenth century when it was observed that some individuals, despite the
large intake of food were suffering from substantial weight
loss.

It was postulated that the body was dissolving itself

and was pouring out through the urinary tract.

Thus, the

Greek word diabetes, meaning "running through" and the Latin
word mellitus meaning "honey" or "sweetness" were used
together to describe the major symptom of diabetes, the
excretion of large amounts of sweet urine.

It was not until

the late 1800's that researchers discovered that the oancreas
played an important role in this disease.

The diabetic

condition was induced in experimental animals when the
pancreas was removed.

Some thirty years later, in 1921,

Banting and Best, while working with pancreatic extracts,
2
Up until the discovery of insulin,
1 in.
·
d.iscovere d insu
.
diabetics survived not more than a few years after diagnosis.

2.

Treatment with insulin prevented death from diabetic coma
and controlled many of the overt symptoms of the disease.
With the increase in the life expectancy of individuals with
diabetes

came the discovery of many comolications
·' such as

cardiovascular disease, retinopathy, and kidney disease.
Since Banting's and Best's discovery of insulin more has
been learned about the complexity of the pancreas.

It is a

bifunctional organ with both exocrine and endocrine functions.
The endocrine constituent is composed of the islets of
Langerhans.

The islets contain a variety of cell types:

the

alpha cells which secrete glucagon; beta cells which secrete
insulin; delta cells which secrete somatostatin; and the PP
cells which secrete pancreatic polypeptide.

Although all may

be indirectly involved in diabetes, research is primarily
interested in the beta cells and their role in diabetes.
Today, diabetes affects almost 5% of the oopulation.

It

is the third ranking cause of death in the United States,
after heart disease and cancer.

In 1975, the National Com-

mission on Diabetes related some of its findings to Congress.
The statistics and findings werP.:
Diabetics are 25 times more prone to blindness than
nonctiabetics; 17 times more prone to kidney disease, 5
times more prone to gangrene; and 2 times more prone to
heart disease.
The life expectancy among oeople with diabetes is
one third less than that of the general population.
Women are 50% more likely than men to have diabetes,
non-whites are 20% more likely than whites to have
diabetes.

3.

The enconomic toll of the disease, not counting its
complications, is estimated to be $ 5 .3 billion every
year.3
Based on its findings, the Commisssion advised that a
long range plan be put into effect.

They saw the need for

diabetes research programs, diabetes training centers, and
diabetes education.

The Commission formed the National

Diabetic Advisory Board.

The Boards mission was to implement

the Commissions
.
.
p lans. 3

Since the findin9s of the Commission, research in diabetes has continued

to flourish.

Several approaches to the

problem have been taken; one course of action has been toward
finding the cause or causes for diabetes.

Over the years

several ideas have been advanced to try and explain the
etiology of this disease.

One suggested that the immune

system may be responsible, while another suggested that an
individual must have the correct genetic predisposition to
develop diabetes, and still another suggested that the cause
4
lies in an infectious etioloty. , 5
As far back as 1 899, when Harris reported that diabetes
developed in a patient shortly after an infection with mumps
virus, researchers have considered the oossibility of virus

induced diabetes.6 Other viruses that have been associated
with diabetes include:

group B coxsackievirus; reo; rubella;

influenza; cytomegalovirus; polio; measles; and tick borne
encephalitus.7 • 8

4.

Evidence supporting the involvement of these common
human viruses is minimal at most, with one exception.

Con-

siderable evidence has now accumulated whic:1 suggests that the
group B coxsackieviruses cause diabetes in man.

In 1969,

Gamble and associates found that titers of neutralizing antibody to CB4 were higher in newly diagnosed diabetic patients
when compared to non-diabetic controls.

The same correlation
q

did not exist with the other common viruses they tested.�

Then in 1979, Yoon and associates, working with a 10 year old
diabetic found that the patient's diabetes was probably virus
induced.

The patient was hospitalized with diabetic ketoacid-

osis and 3 days later he died.

Studies showed lymphocytic

infiltration of the islets of Langerhans and necrosis of beta
cells.

Serological analysis showed a rise in neutralizing

antibody to vi��s frcm less than 4 on the second day in the
hospital to 32 on the day of his death.

Virus was isolated

from the liver, pancreas, and other organs.
.
10
data showed that the virus was CB4 .

Neutralization

Most evidence supporting the involvement of viruses in
diabetes has been provided by studies with experimental
animals, especially mice.

The M variant of encephalo-

myocarditis (MEMC) virus has proved to be an excellent model
for viral induced diabetes using "susceptible" and "nonsusceptible" strains of mice and the hybrids.

In susceptible

strains of mice, the virus infects the insulin producing beta
cell of the pancreas, producing hypoinsulinemia, hyperglycemia, and abnormal glucose tolerance tests.

The nonsuscep-

5.

tible strains become infected, however, there is no apparent
infection in the beta cells and diabetes-like symptoms do not
develop.

The determining factor in susceptibility appears to

be in the genetic prectisposition of the host to allow virus
13
replication in the beta cells.
The MEMC virus model has proved useful, however, EMC
virus is not a co11Unon pathogen of humans.

Considerable

interest has now focused on the group B coxsackieviruses
(CB).

CB viruses are related to the EMC virus; they are both

Picornaviruses.

Coxsackievirus, group B, type 4 (CB4)

infects mice and produces a generalized disease very similar
to that produced in man.
7
species.

Also, CB4 is pancreatropic for both

In 1980, Webb and associates suggested that the gene or
genes which control the susceptibility of mice to MEMC virusinduced diabetes may also be responsible for the induction of
diabetes by CB4 virus.

Using mice that were susceptible and

nonsusceptible to the MEMC virus; they inoculated each group
of mice with CB4 virus.

There was a positive correlation

between MEMC virus susceptibility and CB4 induced beta cell
degranulation.

They concluded that physically and chemically

similar viruses, such as MEMC and CB4, may share a co11Unon
receptor on the cell surface, and as a result the host res. ·
12
A number of important contribuponse would be s1m1 1 ar.
tions by others had preceeded their observations and heloed
establish the relationship between CB4 and diabetes-like
disease in animals.

6.

In 1974, Coleman and associates induced diabetes in 20%30% of the adult male CD-1 mice that they inoculated with
CB4 virus.

Histology showed slight damage to both the islet

and acinar tissues. 13

Ross and Notkins, however, reported

the opposite results.

Using prototype strains of CBl, CB3,

CB4, and CBS viruses and CD-1 male mice, they produced hyperamylasaemia and a decrease in the amylase content of the
pancreas.

The non-fasting glucose levels and glucose toler-

ance test, however, were normal under a variety of experimental conditions.

The hyperamylasaemia found during acute

infection supported the pathological changes of acinar pancreatitis.

Non-fasting glucose levels and glucose tolerance

test failed to reveal evidence of glucose intolerance.
Furthermore, they found no beta cell damage.

They concluded

that there was not enough evidence to support the theory that
·
·
14 Data of
.
CB4 viruses
cause d.1abetes-1 .1ke syndrome in mice.
others support these observations that CB4 does not induce
.
15
d.1abetes-1 1· ke d.1sease .in mice.

In another article that

same year, Ross and Notkins suggested that variations in the
virus or in susceptibility of the host to infection might be
important factors in the production of diabetes and might
explain conflicting results� 6
In an effort to explain conflicting results, some
researchers turned their efforts towards determining if there
were variations in the susceptibility of the host to infection.

Specifically, they wanted to know if the pancreas was

7.

susceptible to various viruses and if these viruses would
replicate in the pancreas.

As early as 1951, Pappenheimer

reported severe pathological changes in the pancreas of
sexually mature mice when inoculated with CBS virus.

He

observed massive necrosis of the acinar tissue, but the
17
islets of Langerhans were resistant to destruction.

Then

in 1971, Burch and associates inoculated mice with CB4 virus.
Histological studies showed significant cellular alterations
in the exocrine and endocrine pancreas.

Electron micrographs

showed degranulation and cellular disruption of the islet
cells.

He postulated that viral pancreatitis may cause sub-

clinical diabetes as well as overt diabetes mellitus in
varying degrees. 18

It was not until the late 1970's that

there was substantia l evidence that the pancreas was susceptible to infection and that the CB viruses actually replicated
in the pancreas.

In 1978, using cultured human beta cells

and radioinununoassay, Yoon and associates showed intracellular
inununoreactive insulin decreased rapidly beginning at 24 hours
post infection with a CB3 virus.

The decrease was roughly

paralleled with the increase in viral titer.

By use of

double-label antibody, they were able to demonstrate that the
beta cells in these cultures were susceptible to infection
by CB3 virus.

In conclusion, they postulated that in vitro

human beta cells would replicate the CB3 virus. 19

Then in

1979, they inoculated mice with a human isolate of CB4.

The

mice became hyperglycemic with inflammatory cells in the
islets and beta cell necrosis.

They then stained the pancreas

8.

sections with florescein-la bel
CB4 vir a l

a ntigens

time, Prince
would

a lso

Yoon

a ntiviral a ntibody a nd

in the bet a cells.lo

a nd a ssoci a tes

found

Around the s a me

demonstr a ted tha t mumps virus

replic a te in cultured hum a n bet a cells.20

a nd

associ a tes con eluded " ...the most plausible

explanation for these conflicting reports (concerning CB
vir a l-induced di a betes) would
most strains of CB virus
if bet a cells

a re

a re

a ppe a r

to be tha t in mice ,

minimum ally beta tropic

a lter a tions

in glucose met abolism". 21

With this in mind, they passed virus in beta cells.
a nimals

were inoculated with p a ssed

a nd

Experi-

unp a ssed virus.

The unpassed virus failed to r a ise the glucose index a
control valves.

th a t

dam a ged, the number is usu a lly insufficient

to produce subst a nti a l
ment a l

a nd

a bove

Virus p a ssed 3 times in the bet a cells

showed elevated glucose indexes; virus p a ssed 5 times induced
di a betes in 35% of the

a nima ls;

virus p a ssed 14 times induced

di a betes in 80% of the

a nim a ls.

The unpassed virus f a iled to

produce di a betes even when high titers of virus were used.
Yoon

a nd a ssoci a tes

noted tha t only the beta cells of some

str a ins of mice replicated the virus.
the 9ass a ge history of the virus

a

a nd

They concluded tha t

the str a in of the host

Glucose index wa s used by Ross a nd Notkins to give added
weight to the presence of non-f a sting hyperglycemi a. Glu
(4 x NF d a y 14) + (3 x NF day 7)
cose index is defined as:
+ (2 x GTT d a y 17) + (1 X GTT d a y 10) divided by 10.
Ross, M.E., T. Onoder a , K.S. Brown, A.L. Notkins. Virus
induced Di abetes Mellitus IV. Diabetes 25: 190, 1976.

9.

influence the development of diabetes.21
Much work has been done to determine the susceptibility
of the various strains of mice to diabetes, however, little
definitive work has been done with the passage history of the
virus, yet its influence in the consequence of viral pathogenesis has been known since 1952.

Dalldorf and associates,

while working with viruses and the pancreas, suggested that
anatomic comparisons should take into account the past histories of the strains of viruses and the methods used in
their propagation. 22 Lansdown worked with CB virus and
concluded, as Ross and Notkins, that CB virus does not
produce diabetes-like changes in islet cells.

However, he

said that it was apparent that much further work is required
to understand the variations in the pathogenicity of the CB
.
viruses. 23
Hartig and Webb in 1983, showed that one human isolate
of CB4, Edwards, contained several strains of virions.
were able to isolate 3 strains which were designated:
and E3.

They
El, E 2,

The 3 strains were similar serologically, they

showed identical plaque morphology, and replicated to similar
levels in the mouse pancreas.

The three isolates varied in

their capacity to accumulate virus antigen within the islet
cells of genetically similar mice.

They concluded that the

difference in the infecting particle is probably a genetic
difference.

The pathological consequence and expression of

any diabetogenic potential is,therefore,dependent on virus
strain selection. 24

10.

In another study, Hartig and Webb examined the biological
properties of CB4 Edwards, El, E2, and E3 during the acute
phase of infection.

They showed that although the isolates

were similar serologically, they differed in their biological
properties.

The original virus, CB4 Edwards, induced an

increase in plasma amylase in SWR and 6J mice.

Ar:tylase con-

centrations were not affected in the SWR mice inoculated with
the E2 isolate.

El and E2 did depress blood glucose levels,

yet failed to produce a rise in plasma insulin levels in the
SWR mice.

The CB4 Edwards, however, did induce a rise in

plasma insulin levels in this strain.

El also produced a

hypoglycaemic state in the 6J mice without altering plasma
insulin concentrations.

Hartig and Webb concluded that...

"the data collected demonstrate differences between CB4 virion
populations and the pathologies which can result from infect25
ion with specific virions as well as the total virus pool."
Most evidence to date clearly indicates that CB4 virus
can affect the pancreas of both man and mice during acute
infection.

Yet, conflicting evidence exists relative to the

consequence of the infection in both man and mice.

The study

described here attempted to provide definitive evidence on the
relative role of the virus isolate (i.e. heterogenous virion
populations vs. purified clones) in induction of prolonged
diabetes-like disease in mice.

Materials and Methods

I.

VirUEeS
Six isolates of the coxsackievirus, group B, type 4

(CB4) were used in this study:

human isolate �owers (Pow)

human isolate Edwards (Edw); purified isolate Edwards 1 (El)
purified isolate Edwards 2 (E2); ourified isolate Edwards 3
(E3); and purified isolate Edwards 2 passed in cultured mouse
islet cells (E2i) .

Although some of these viruses may be

subtypes or strains, all have been called isolates here,
since insufficient data exist to allow the differentiation of
one from the other.
The virus, CB4 Pow was originally isolated by Kibrick
and Benirschke in 1958 from an infant who died from resoira

tory failure and gastrointestinal and oulmonarv hemorrhages.26
The virus was isolated from myocardial, liver, and soinal

cord tissue by growth in cultured monkey renal cells and
identified as a CB4 by neutralization with type-specific
antisera.

The virus was obtained from Kibrick and pools of

the virus were obtained using cultured Hela cells.
The virus, CB4 Edw was also originally isolated by
26
.
Kibrick and Benirschke in 1958.
It was isolated from
heart, liver, and spleen tissue of an infant who died from

12.

encephalohepatomyocarditis.
and identified as CB4.

The virus was similarily grown

Webb and associates have documented

the passage history of CB4 Edw as well as its pathogenesis in
various strains of mice.27, 12

Hartig and Webb purified the CB4 Edw; three plaque
purified isolates were chosen.
and E3.

These were designated E1, E 2 ,

The passage history of these three isolates was

recently documented by Hartig and Webb. 24

The E 2 i isolate was the product of passing the E 2
isolate sequentially 5 times in cultured islet cells derived
from C57BL/6J mice.
The titer of the various viruses was determined using a
plaque assay.

Cultured Buffalo Green Monkey (BGM) kidnev

cells and methyl cellulose, an overlay medium, were used in
this assay.
II.

Mice
Mice of the outbred strain CD-1 were obtained from

Charles River Breeding Laboratories (Dublin, Virginia).

The

mice were housed 5 to a cage and fed either Purina Lab Chow
(phase I animals) or Purina Mouse Chow (phase II animals).
The animals were allowed food and water ad li_bitum.

Light(l2 :12)

and temperature (25° c) were maintained in the animal facilitv.
The mice were maintained and used according to the guidelines
established by the National Research Council in DHEW
publication number (NIH) 73- 2 3.

13.

III.

Experimental Design
In the first phase of the experiment, 6- 7 week old male

CD-1 mice were were divided into 6 groups with 20 animals in
each group.

Each group was inoculated i�

with 1 x 10 4 pfu

of either Pow, Edw, E1, E2, E3 or E2i isolate of the CB 4 .

The animals were administered glucose tolerance tests (GTT)
at 3, 6, 9, and 12 weeks post infection.

Within 7 days after

the final glucose tolerance test, the animals were fasted
overnight and all sacrificed.
examined:

The following parameters were

concentration of pancreatic protein and insulin;

concentration of plasma insulin; and serur1 titer of neutralizing
antibody to the homologous CB 4 virus.
During the second phase of the exPeriment, 6-7 week old
male CD-1 mice were divided into 2 groups with 20 animals in
each group.

Each group was inoculated i p

with 1 x 10 7 pfu

of either the Edw isolate or the E2i isolRte of the CB 4 .

Again, glucose tolerance tests were administered at 3,
and 12 weeks post infection.

7,

9,

After 12 weeks post infection,

three animals from each group were fasted overnight, sacri
ficed and examined as before.
Uninfected animals of the same strain, age, and sex were
carried throughout the experiments.

Thev were used as

controls for each assay conducted on the infected animals.
V.

Techniques

Glucose Tolerance Test/Glucose Assay
Glucose Challenge was ac�teved by injecting each animal

14.

ip.

•·•ith 2 mg of glucose per gram body weight.

was a 20% aqueous solution.

The glucose

Ten microliters of tail blood

was collected prior to challenge and then 30, 60, and 120
minutes post challenge.
of 2% perchloric acid.

Each samole was suspended in 150 µl
°

After storing overnight at 4 c, the

samples were centrifuged at ;moo x g for 20 minutes.

Fifty

microliters of the supernatant from each sample was assayed
for glucose by the glucose oxidase procedure as described by
28
Chick.
Analysis of the Pancreas
Twelve weeks after infection, the animals were sacrificed and a portion of the endocrine pancreas was removed.
Sare of the tissue was frozen and t."le rest
neutral buffered formalin.

was fixed in

The fixed tissue was imbedded in

paraffin, sectioned, and stained with hemotoxyin and eosin.
Other sections were stained for insulin granules by the
aldehyde fuscin method.
The frozen tissue was later thawed and weighed.

The

pancreatic tissue was homogenized in 2 mls phosphate buffered
saline (PBS) per 0.1 g of pancreas.

This is the stock homo-

genate from which other dilutions were made for pancreatic
protein and insulin determinations.
Protein concentrations were determined by the method of
Kalb and Bernlohr which uses the ratio of light absorbance
at 230 and 260 nm
equation:

( 183

X

can be expressed by the following
29
This method of
A230 - 7. 5 X A260) ·
and

15 .

protein analysis was compared with a standard protein assay
and found to be comparable for the quantitation of ?rotein
in pancreatic homogenates and purified solutions of bovine
serum albumin and hyaluronidase.
Radioirnrnunoassay, as described by Yalow and modified by
Weir, was used to determine the concentration of insulin in
30,31
the pancreas.
This method employed the use of a single
antibody, guinea pig-antiporcine insulin antibody, charcoal
dextran (T-70 Pharmcia) extraction.

The charcoal pellet was

counted in a Beckman Gamma 8000 for percent unbound insulin.
The pancreatic insulin was obtained by extracting 1 ml
°

of the pancreatic homogenate overnight at 4 c in 1 ml of 2%
perchloric acid.

The extraction solution was diluted in °BS

to adjust the pH to 7 and to bring the concentration into
range for the assay.
Serum Analysis
The serum of selected animals was collected after
sacrifice for the analysis of neutralizing antibody.

The

antibody titers were determined using a neutralization test.
The serum was diluted via a 2 fold serial dilution beginning
at a 1/40 dilution.

Using a 96 well tray, the various

dilutions of the serum were allowed to react with 100 TCID
of homologous virus for approximately 1.

5

°

hours at 37 c.

50

BGM cells (10 5 ) were added to each well and 48 hours later
the trays were fixed and stained with crystal violet.

Anti-

body titers were calculated as the inverse of the highest

16.

dilution that exhibited virus neutral ization.
Radioimnunoassay, as described above, was used for the analysis of
, Jl
insulin concentrations in the serum.30
Statistical Canparisons
Statistical Canparisons were made by either a 1-way or a 2-way
analysis of variance follc:wed by p:>st-hoc canparisons with a Tukey
test.

'Groups' is defined as weeks p:>st infection.

as minutes after glucose challenge.

'Ti.Ire' is defined

Results
GLucose Tolerance Tests
Results of individual GTT of mice infected with CB4 Pow
are shown in Fig. l.

When each time at 3, 6, 9, and 12 weeks

post infection was expressed as a mean and compared with the
controls, as shown in fig. 2, a definitive pattern aooeared.
A 4 x 4 ANOVA with repeated measures across time revealed a
significant effect between groups, F(3,36) = 21.57, P<J.001 and
across times F(3,108)=97.65, P<0.001.

In addition, the

groups by time interaction, F(9,l08)=7.58, p<0.001, was
significant.

Post-hoc comparisons with a Tukey test (P<0.05)

revealed that the Pow virus was significantly different from
the control group at 6 weeks (30, 60, and 120 min. post
challenge) and at 9 weeks (30 and 60 min. post challenge)
post infection.

Data from the 3 mice examined at 12 weeks

were not included in these comparisons.
Results of individual GTT mice infected with CB4 Edw are
shown in fig. 3.

When each time at 3, 6, 9, and 12 weeks

post infection was expressed as a mean and compared with the
controls, as shown in fig. 4, a definitive pattern appeared.
A 4 x 4 ANOVA with repeated measures across time revealed a
significant effect between groups, F(3,37J = 29.61, p < 0.0001
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and across times, F(3,110J=66.52, p<0.0001.

In addition, the

groups by times interaction, F(9,ll0)=4.75, p<0.001, was
significant.

Post-hoc comparisons with a Tukey test (r<0.05)

revealed that the Ectw virus was significantly different from
the control group at 6 weeks (30, 60, and 120 min. post chal
lenge) and at 9 weeks (30 and 60 min. oost challenge) post
infection.

Data from the 3 mice examined at 12 weeks were

not included in these comparisons.

Figure 1:

Results of individual GIT of mice infected with CB4 Pew at
a.) 3 weeks post infection, b.) 6 weeks post infection, c.)
9 weeks post infection, and d.) 12 weeks post infection.
The line represents the
of the control animals.
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Figure 2:

Results of individual GIT of mice infected with CB4 �'
expessed as means and cx:impared to the IIEan values of
the results of individual GIT of the control mice.
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Figure 3:

Results of individual GIT of mice infected with CB4 F.dw at
a.) 3 weeks post infection, b.) 6 weeks post infection, c.)
9 weeks post infection, and d.) 12 weeks post infection.
The dotted line represents the rrean non-fasting glucose
level of the control animals.
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Results of individual GTT of mice infected with CB4 El
are shown in fig. 5.

When each time at 3, 6, 9, and 12 weeks

post infection are expressed as a mean and com9ared with the
controls, as shown in fig. 6, a definitive pattern appeared.
A 4 x 4 ANOVA with reoeated measures across times revealed a
significant effP.ct between grouDs, F(3,36)=35.26, n< 0.001 and
across time, F(3,108)=58.59, p<0.001.

In addition, the groucs

by time interaction, F(9,108)=5.17, o< 0.001, was significant.
Post-hoc comparisons with a Tukey test (r,<0.05) revealed that
El was significantly different form the control group at 6
weeks (30, 60, and 120 min. post challenge) and at 9 weeks
(30, 60, and 120 min. post challenge) post infection.

Data

from the 3 mice examined at 12 weeks were not included in
these experiments.
Results of individual GTT of mice infected with CB4 E2
are shown in fig. 7.

\�hen each time at 3, 6, 9, and 12 weeks

post infection was exoressed as a mean and compared with the
controls, as shown in fig. 8, a definitive·pattern aoceared.
A 4 x 4 ANOV� with repeated measures across time revealed a
significant effect between grou?S, F(3,36)=7.6 5, r <0.001 and
across times, F(3,10�)=72.18, p<0.001.

In addition, the

groups by time interaction, F(9,108)=5.86, r< 0.001, was signi
ficant.

Post-hoc comparisons with a Tukey test (p<0.05)

revealed that E2 was significantly different from the control
group at 3 weeks (30 min. cost challenge), 6 weeks (30, 60,
120 min. post challenge), and 9 weeks (30, 60, and 120 min.
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post challenge) post infection.

Data from the 3 mice

examined at 12 weeks were not included 1n these comparisons.

Figure 5:

Results of individual GIT of mice infected with CB4 El
at a.) 3 weeks post infection, b.) 6 weeks post infection,
c.) 9 weeks post infection, and d.) 12 weeks post infection.
The dotted line represents the mean non-fasting glucose
level of the control animals.
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Figure 6:

The results of the individual GIT of mice infected with CB4
El expressed as rreans and c::arpared to the mean values of
the results of individual GIT of the control mice.
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Figure 7:

Results of individual GIT of mice infected with CB4 E2 at
a.) 3 weeks post infection, b.) 6 weeks post infection, c.)
9 weeks post infection, and d.) 12 weeks post infection.
The dotted line represents the rrean non-fasting glucose
level of the control animals.
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The results of the individual GIT of mice infected with
CB4 E2 expressed as means and cx:rnpared to the mean values
of the results of individual GIT of control mice.
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Results of individual GTT of mice infected with CB4 E3
are shown in fig. 9.

\�hen each time at 3, 6, 9, and 12 weeks

post infection was expressed as a mean and compared with the
controls, as shown in fig. 10, a definitive pattern appeared.
A 4 x 4 ANOVA with repeated measures across times revealed a
significant effect between groups, F(3,37J=l5.90, n<0.001 and
across times, F(3,111)=91.72, p<0.001.

In addition, the

groups by time interaction, F(9,111)=6,63, p<0.001, was signi
ficant.

Post-hoc comoarisons with a Tukey test (p<0.05)

revealed that E3 was significantly different from the control
group at 3 weeks (30, 60, and lLO min. post challenge), 6
weeks (30, 60, and 120 min. post challenge), and 9 weeks (30,
60, and 120 min. post challenge) post infection.

Data from

the 3 mice examined at 12 weeks were not included in these
comparisons.
Results of individual GTT of mice infected with CB4 E2i
are shown in fig. 11.

When each time at 3, 6, 9, and 12

weeks post infection was expressed as a mean and compared
with the controls, as shown in fig. 12, a definitive pattern
appears.

A 4 x 4 ANOVA with repeated measures across times

revealed a significant effect between groups, F(J,37) = 8.67,
p <0.001 and across time, F(3,lllJ=72.87, p<0.00 1 .

In

addition, the groups by time interaction, F(9, 1 1 1 )=6.08,
P<0.001, was significant. Post-hoc comparisons with a Tukey
test (p<0.05) revealed that E2i was significantly different
from the control group at 3 weeks (30 and 60 min. oost
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challenge), 6 weeks (30 and 60 min. post challenge), and 9
weeks (30 and 60 min. post challenge) post infection.

Data

from the 3 mice examined at 12 weeks were not included in
these comparisons.

Figure 9:

Results of individual GIT of mice infected with CB4 E3
at a.) 3 weeks post infection, b.) 6 weeks post infection,
c.) 9 weeks post infection, and d.) 12 weeks post infection.
The dotted line represents the rrean non-fasting glucose
level of the control a.nirrials.
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Figure 10:

The results of individual GIT of mice infected with CB4 E3
expressed as means and canpared to the mean values of the
results of individual GIT of a:mtrol mice.
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Figure 11:

Results of individual GIT of mice infected with CB4 E2i
at a.) 3 weeks post infection, b.) 6 weeks post infection,
c.) 9 weeks post infection, and d.) 12 weeks post infection.
The dotted line represents the rrean non-fasting glucose
level of the control animals.
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Figure 12:

The results of individual GIT of mice infected with CB4 E2i
expressed as means and carpared to the mean values of the
results of individual GIT of control mice.
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In the above phase of the experiment, the animals were
inoculated with a single dose of 10

4

pfu of virus.

A second

phase of the experiment was conducted to determine if dose
had any effect on the results.

In this phase, the animals

were inoculated with a single intraperitoneal dose containing
10

7

pfu of either Edw or E2 i virus.

The results of individual

GTT of mice inJected with CB4 Edw high dose (Edw') are shown
in fig. lJ.

When each time at 3, 6, 9, and 12 weeks post

infection was expressed as a mean and compared with the
controls, as shown in fig. 14, a definitive pattern appears.
There was an obvious increase in the post challenged blood
glucose levels at 6, 9, and 12 weeks post infection,
indicating glucose intolerance.
increased mortality.

Edw' also induced an

There was less than 5% mortality in

all other groups, however, the group inoculated with Edw' had
4 0%

mortality.
The results of individual GTT of mice in1ected with CB4

E2 i high dose (E2i') are shown in fig. 15.

When each time at

3, 6, 9, and 12 weeks post infection was expressed as a mean
and compared with the controls, as shown in fig. 16, a
definitive pattern appeared.

There was an obvious increase

in post challenge blood glucose levels at 6, 9, and 12 weeks
post infection, indicating glucose intolerance.
effect

The dose

data £ran infection with Edw' and E2i were included in the

statistical canparisons below to determine differences between
viruses.

Figure 13:

Results of individual GIT of mice infected with CB4 E.dw'
at a.) 3 weeks post infection, b.) 6 weeks post infection,
c.) 9 weeks post infection, and d.) 12 weeks post infec
tion. The dotted line represents the rrean non-fasting
glucose level of the control animals.

Figure 14:

The results of individual GIT of mice infected with CB4
Edw' expressed as means and canpared to the rrean values of
the results of individual GIT of control mice.
( ----) - control � SD
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Figure 15:

Results of individual GIT of mice infected with CB4 E2i'
at a.) 3 weeks post infection, b.) 6 weeks post infection,
c.) 9 weeks post infection, and d.) 12 weeks post infec
tion.

The dotted line represents the rrean non-fasting

glucose level of the control animals.
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Figure 16:

The results of the individual GIT of mice infected with
CB4 E2i' expressed as means and caupared to the mean
values of the results of individual GIT of control mice.
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A sumnary of the results £ran the GIT analyzed by 4 x 4 NJ.OVA and
post-hoc canparisons wht Tukey test are sho,m in table 1 with the main
effects noted for each block canpared with controls. Although there
were a number of significant effects, three times were chosen for
furt.hA..r analysis. The 3 weeks post infection at 60 min. post challenge,
6 weeks post infection

at 60 min. post challenge, and 9 weeks post in

fection at 60 min. post challenge were used to detennine differences
between virus groups by a 1-way NJ.OVA.

At 3 weeks post infection, 60 min.

post challenge, a 1-way ANOVA revealed a significant effect across
viruses, F(8,80)=4.30, p<0.05.

Post-hoc canparisons with a Tukey test

(p<0.05) revealed that Edw was significantly different £ran E2, E3, E2i,
Edw', and E2i', but was not significantly different £ran Po,., or El.
All other canparisons were not significantly different as sho,m in table
2.
At 6 weeks post infection, 60 min. post challenge, a 1-way NJ.OVA
revealed significant effects across viruses, F(8,81)=6.03, p<0.05.
Post-hoc canpariscns with a Tukey test (p<0.05) revealed that the controls were significantly different £ran Po,.,, Edw, El, E2, Edw', and
E2i', but were not significantly different fran E3 and E2i, as sho,m
in table 2.
At 9 weeks post infection, 60 min. post challenge, a 1-way NJ.OVA
revealed significant effects across viruses,F(8,76)=4.09, p<0.05.
Post-hoc canparisons with a TUkey test (p<0.05) revealed that the
controls were significantly different £ran El, E2, E3, and E2i',
but were not significantly different £ran Edw, Po,.,, or E2i. All other
·
as sho,m in table 2.
canparisons were not significantly different,
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Table 1.

Post hoc comparisons of a 4 x 4 ANOVA of
GTT results.

3 wks.

6 wks.

wks.

9

0
-

30
-

60
-

120
-

0
-

30
*

60
*

120
*

0
-

30
*

60
*

120
-

-

-

-

-

-

*

*

*

-

*

*

-

El

-

-

-

-

-

*

*

*

-

*

*

*

E2

-

*

-

-

-

*

*

*

-

*

*

*

-.

*

*

*

-

*

*

*

-

*

*

*

-

*

*

-

-

*

*

-

-

*

*

-

Pow
Edw

E3
E2i

*Significant at p<0.01 when compared to the control group.
Each virus constituted a separate ANOVA.
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Table 2.

Post-hoc comparisons of 1-way ANOVA of GTT
results to detect differences between viruses.

3 Weeks*

6 Weeks

9

Weeks

E3

A

El

A

E3

E2i

A

A

Pow

A

E2

Edw'

A

A

E2i'

A

E2i'

A

E2i'

A

Edw'

A

El

A

E2

A

Edw

A

Edw'

A

Pow

A B

E2

A

E2i

A B

El

A B

E3

A B

Edw

A B

Controls

A B

E2i

A B

Pow

A B

Edw

B

Controls

B

Controls

*Viruses scored with the same letter are not significantly
different.
3 weeks, 6 weeks, and 9 weeks each constitute a separate
1-way ANOVA

B
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Neutralization Test
Results for neutralizing antibody are shown in table 3.
Representative animals were selected and examined after 12
weeks post infection for neutralizing antibody to virus,
these are the mice for which 12 week GTT were run.

The

presence of neutralizing antibody would be supportive
evidence that the animals had significant neutralizing anti
body to the coxsackie virus with which it was inoculated
(homologous virus/serum reaction).

There was no ap�arent

correlation between GTT results of these individual mice
and their respective level of antobody to the virus (see 12
week GTT levels).
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Table 3.

Test for Ne u tr a lizi ng An tibody.
Vir u s
Pow

Edw

El

E2

Ab level
320

a

320
320
160

160

160
160

320

40

1280

640

160

320
E3

320

320
1280

E2i

320

1280
160

Edw'

160

80

640
E2i'

a

640

320

Antibody ti ters wer e c alculated as the i nvers e of the
highest d i lu ti o n of serum that exhibited virus neutr alization.

Each number represents a different animal.
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Serum IRI
Serum immunoreactive insulin levels were generally quite
low as detected by our radioinununoassay system.
sensitivity of the assay

The lack of

prevented accurate determination of

serum immunoreactive insulin levels.

Therefore, these data

were not compared statistically and are not presented.
Histology
The pancreases of mice from each group were examined by
light microscopy after staining with hemotoxylin and eosin
and with aldehyde fuscin.

The observations were qualitative

and no attempt was made to estimate the relative endocrine/
exocrine volume.

The pancreases of all mice examined were

unremarkable.

All showed normal cell confirmation and tissue

architecture.

The beta cells in the islets of Langerhans

from both control and virus grou�s were well granulated with
insulin.

There was no evidence of inflammation, necrosis,

fatty replacement or other pathologies characteristic of
acute CB viral infection of the pancreas.
Extractable Immunoreactive Insulin
Pancreatic insulin data are shown in fig. 17.
level of extractable

�he mean

immunoreactive insulin of controls was

32 � 16 uU/ug extractable protein.

The mean levels of

extractible immunoreactive insulin at 12 weeks after infection
with any of the viruses was less than the control level.
One-way ANOVA, F(6,93)=20.51 , p<0.05, showed that there was a
significant effect across groups.

Post-hoc comparisons with

Figure 17:

Mean values ± SD of the extractable pancreatic irrmun.ore
active insulin expressed as uU of insulin per ug extract
able protein.
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a Tukey test (p<0.05) revealed that all viruses were signifi
cantly different from the controls.

However, there was no

significant difference between viruses.
Weights
All animals were weighed periodically; the primary times
were before glucose tolerance tests and these weights are
shown in fig. 18.
12 week period.

All animals increased in weight over the
However, most infected animals lost weight

during the acute stage of infection which was expected.
Weight has never correlated with viral-induced diabetes in
mice and thus they were not critically analyzed here.

Figure 18:

Mean values:!: SD of the l:x:xly weights (g) across tirre(wks)
for controls and each of the virus groups.
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Discussion
In recent years, the idea of a viral etiology in
diabetes mellitus in man has been revived by a few new case
studies and strong support from numerous experiments with
mice.

The most convincing data have been generated by Yoon

and Notkins and associates using a laboratory-derived strain
of encephalomyocarditis (EMC) virus in inbred mice.

They

have, along with others, including Webb and associates,
shown that the common human virus, Coxsackievirus, group B,
type 4 (CB4) can cause diabetes-like disease in mice of
specific genetic background, but not in others.

Unlike the

data presented from this study, most other studies have been
of a short term nature, that is, most have been terminated
at or before 3 weeks post infection.

If within this brief

period, the experimental subjects did not (1) exhibit
abnormal fasting or nonfasting blood glucose levels,

(2) have

inappropriate responses to glucose challenge during GTT, or
(3) have an abnormal "glucose index", it was concluded that
the animals were not diabetic.

If, however, any one of the

conditions were detected, it was taken as evidence for viral
induced diabetes.
justified.

The latter conclusion was appropriate and

However, the former conclusion based on negative
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responses within 3 weeks of infection were apparently
not

true.

In light of the new findings detailed in this report,

the one most important detail in the experimental design may
not be host genetics or virus genetics, but simply time.
That is the host and viral genetics undoubtedly exert a
strong influence on the pathogenesis, but if the experimental
design precludes detection of subtle changes that do not
become apparent for several weeks after infection then
erroneous conclusions are made.
Using six isolates of CB4, the blood glucose levels
were monitored for 12 weeks.

GTT were performed over the

period and all data except the 12 week GTT data were subjected
to statistical analysis.

Results of GTT's indicated that

half of the groups inoculated with the isolates were
significantly different from the controls at 3 weeks.

Thus,

by most criteria only 3 of the 6 virus isolates would be
considered diabetogenic.

Previously, statistical analysis

was not applied to the results of GTT.

Abnormal blood glucose

levels have been determined by a glucose index or by other
requirements such as 3 of the 4 GTT values being elevated.
By the former analysis, only two of the six isolates used in
this study would be classified as diabetogenic while analysis
by the latter, would classify only of of the six isolates as
diabetogenic.

statistical comparisons are, therefore, use-

ful tools in analyzing GTT data, in that they can provide a
uniform method of analysis and interpretation.
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Statistical analysis of GTT data at 6 and 9 weeks post
infection revealed that all virus isolates were significantly
different from the controls.

These elevated blood glucose

levels indicate glucose intolerance and the viral-inducation
of diabetes in the experimental animals.

Since this condi-

tion was not manifested until 6 weeks post infection, one
must question the relative weight that should be given to
data from experiments which were terminated at or before the
end of 3 weeks post infection.

Statistical analysis of the

extractable pancreatic immunoreactive insulin concentrations
revealed that all of the virus groups had a significantly
lower concentration than the control group.

The insulin

data lend support to the observation that the glucose intolerance induced in the experimental animals was indeed a
direct reflection of an insulin deficit.

By even the most

conservative criteria for experimental animals, many of
these mice would be classified as diabetic.
Since all six virus isolates did induce diabetes-like
disease in the mice,

then examined for a dose effect

I

using two of the isolates.
ments (10

7

pfu

The results of high dose experi-

4

vs. 10 pfu) showed a definitive dose effect

with both isolates, Edw and E2i, when compared to the data
of the previous low dose experiment.

These data suggest,

as expected, that dose may influence the ultimate consequence
of viral infection.
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Host genetics have been shown to influence the outcome

of infection with the viruses thought to be capable of

inducing diabetes.

Inbred mice have proved valuable in

establishing that host genetics does play a major role in
viral pathogenesis.

The use of outbred mice, such as the

CD-1 strain used in these studies, have generally been dis
continued since more dramatic viral effects can be demonstrated in some inbred strains.

Outbred mice were chosen

for this study to help ensure a genetically diverse host
system so that the specific influence of host genetics could
be minimized.

Thus, interpretation of the results here

depended mostly upon the other primary variable -- that is
the virus.
Virus genetics play an important role in the diabetogenie potential of a virus.

Hartig and associates and

Toniolo and associates have demonstrated that intratypic
variations exist within the CB4 virus.

The former used

clone selectiori by plaque purification, while the latter used
sequential islet cell passage.

Both, however, concluded

that these variations influence the diabetogenic potential
of the CB4 virus.

The data presented in this study agrees

and disagrees with their conslusions.

At 3 weeks post

infection, there was a significant difference inthe diabeto
genic potential of the Edw isolate and all of its clones.
By six weeks, there was no significant difference in the
diabetogenic potential of any of the isolates.

Therefore,

71.

evaluating the ultimate diabetogenic effect of CB4 virus in
experimental mice, one must consider the results in relation
to several factors.
previously believed.

Time appears to be more critical than
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